Related Experiment Video
Updated: Sep 6, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Multimorbidity and Employment Outcomes Among Middle-Aged US Cancer Survivors
Christine C Ekenga1, BoRin Kim, Eunsun Kwon
1From the Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia (Dr Ekenga); Department of Social Work, University of New Hampshire, Durham, New Hampshire (Dr Kim); MSW Program, School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, New Jersey (Dr Kwon); Brown School, Washington University in St. Louis, St. Louis, Missouri (Dr Park).
Objective:
The objective of this study was to evaluate the relationship between multimorbidity and subsequent 2-year employment outcomes among middle-aged United States (US) cancer survivors. In addition, we examined whether the relationship differed by survivor characteristics.
Methods:
Data of 633 cancer survivors (ages 51 to 64) from the 2014 Health and Retirement Study were used to identify multimorbidity profiles and evaluate associations between multimorbidity and prolonged unemployment during follow-up.
Results:
Approximately 64% of cancer survivors met the criteria for multimorbidity. Latent class analysis revealed three distinct multimorbidity profiles distinguished by the presence or absence of psychiatric disorders. We observed a significant association between high psychiatric multimorbidity and prolonged unemployment after 2-year follow-up (relative risk = 2.78, 95% Confidence Interval = 1.28 to 6.00), with the effect more pronounced among low-income survivors.
Conclusions:
Psychiatric multimorbidity was associated with prolonged unemployment among middle-aged cancer survivors, particularly among low-income survivors.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
Longitudinal Research
Psychoneuroimmunology: Diabetes and Cancer

